81801-12-9 xamoterol
상품명칭 |
xamoterol |
영문 이름 |
xamoterol;Xamoterol [USAN:INN:BAN]; Xamoterol; (+-)-N-(2-((2-Hydroxy-3-(p-hydroxyphenoxy)propyl)amino)ethyl)-4-morpholinecarboxamide; 4-Morpholinecarboxamide, N-(2-((2-hydroxy-3-(4-hydroxyphenoxy)propyl)amino)ethyl)-, (+-)-; UNII-7HE0JQL703; Xamoterolum; Xamoterolum [Latin]; N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide |
분자식 |
C16H25N3O5 |
분자량 |
339.3868 |
InChI |
InChI=1/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22) |
cas번호 |
81801-12-9 |
EC번호 |
277-319-9 |
분자 구조 |
|
밀도 |
1.265g/cm3 |
비등점 |
651.4°C at 760 mmHg |
굴절 지수 |
1.571 |
인화점 |
347.7°C |
증기압 |
7.41E-18mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|